Taft Chicago partner and chair of the Pharmaceutical & Life Sciences Litigation practice, Stephen R. Auten, has been named a Life Sciences “Star” by LMG Life Sciences. The annual awards recognize key law firms, lawyers and the innovative work being accomplished throughout the life sciences industry. The awards were given out at a ceremony on Sept. 19 in New York.

Auten is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators and others on his LinkedIn blog, “Hatch Waxman ANDA Litigation Forum,” which has more than 8,900 members worldwide. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation and biosimilar market opportunities.